Depression (major depressive disorder) - Symptoms, Causes, Treatment & Prevention

```html

Overview

Major depressive disorder (MDD), commonly called depression, is a mood disorder characterized by persistent feelings of sadness, loss of interest in previously enjoyed activities, and a range of physical and cognitive symptoms that interfere with daily functioning. It is more than just “feeling down”; the symptoms last at least two weeks and represent a change from a person’s usual mood and behavior.

Depression can affect anyone, regardless of age, gender, ethnicity, or socioeconomic status, but certain groups experience higher rates:

• Women are about 1.5–2 times more likely than men to be diagnosed with MDD.
• People aged 18–29 have the highest prevalence among adults (≈7.8% in the U.S.)<sup>1</sup>.
• Individuals with chronic medical conditions (e.g., diabetes, heart disease) have a 2–3‑fold increased risk.

Globally, the World Health Organization estimates that more than 264 million people live with depression, making it the leading cause of disability worldwide<sup>2</sup>. In the United States, approximately 8.4% of adults (≈21 million) experienced a major depressive episode in the past year<sup>3</sup>.

Symptoms

To meet diagnostic criteria, a person must have at least five of the following symptoms for a minimum of two weeks, and at least one symptom must be either depressed mood or loss of interest/pleasure. Symptoms can vary in intensity and may not all be present.

• Depressed mood – Persistent feelings of sadness, emptiness, or hopelessness most of the day, nearly every day.
• Anhedonia – Marked loss of interest or pleasure in almost all activities.
• Weight/appetite changes – Significant weight loss or gain (≥5 % of body weight) or increase/decrease in appetite.
• Sleep disturbances – Insomnia (difficulty falling or staying asleep) or hypersomnia (excessive sleep).
• Psychomotor agitation or retardation – Observable restlessness or slowed movements/speech.
• Fatigue or loss of energy – Persistent tiredness despite adequate rest.
• Feelings of worthlessness or excessive guilt – Often disproportionate to circumstances.
• Difficulty concentrating – Trouble focusing, making decisions, or remembering.
• Recurrent thoughts of death – Including suicidal ideation, planning, or attempts.

Causes and Risk Factors

Depression is multifactorial; no single cause explains all cases. The interplay of biological, psychological, and environmental factors determines an individual’s vulnerability.

Biological Factors

• Neurotransmitter imbalances – Dysregulation of serotonin, norepinephrine, and dopamine pathways.
• Genetics – First-degree relatives of someone with MDD have a 2–3‑fold higher risk. Twin studies suggest heritability ~37%<sup>4</sup>.
• Hormonal changes – Thyroid disorders, postpartum hormonal shifts, or cortisol abnormalities (stress‑axis dysregulation).
• Neuroinflammation – Elevated cytokines (e.g., IL‑6, TNF‑α) have been linked to depressive symptoms.

Psychological Factors

• History of trauma or abuse.
• Chronic stress, low self‑esteem, or pessimistic personality traits (e.g., perfectionism).
• Maladaptive coping strategies such as rumination.

Environmental / Social Factors

• Major life events (loss of a loved one, divorce, job loss).
• Social isolation or lack of supportive relationships.
• Substance misuse (alcohol, stimulants, opioids).
• Chronic medical illnesses (e.g., cancer, cardiovascular disease).

Diagnosis

There is no laboratory test that definitively diagnoses depression, but clinicians follow standardized criteria and may use screening tools to support the evaluation.

Clinical Criteria

• DSM‑5 (Diagnostic and Statistical Manual of Mental Disorders, 5th edition) – The gold standard in the United States. Requires ≥5 symptoms for ≥2 weeks, with functional impairment.
• ICD‑11 (International Classification of Diseases) – Used worldwide; similar symptom requirements.

Screening & Assessment Tools

• PHQ‑9 (Patient Health Questionnaire‑9) – A 9‑item self‑report scale; scores ≥10 suggest moderate depression.
• HAM‑D (Hamilton Rating Scale for Depression) – Clinician‑administered; useful for severity grading.
• Beck Depression Inventory (BDI‑II) – 21‑item self‑report.

Laboratory & Imaging Studies

These are not diagnostic for depression but help rule out medical mimics (e.g., hypothyroidism, anemia, vitamin deficiencies) and assess comorbidities.

• Complete blood count (CBC), thyroid‑stimulating hormone (TSH), vitamin B12, folate.
• Basic metabolic panel, liver function tests if certain medications are considered.
• Neuroimaging (MRI/CT) only if neurological signs are present.

Treatment Options

Effective management typically combines pharmacologic therapy, psychotherapy, and lifestyle interventions. Treatment is individualized based on severity, patient preference, comorbidities, and prior response.

Medications

• Selective serotonin reuptake inhibitors (SSRIs) – First‑line (e.g., sertraline, escitalopram). Generally well tolerated.
• Serotonin‑norepinephrine reuptake inhibitors (SNRIs) – Venlafaxine, duloxetine – useful when pain symptoms coexist.
• Atypical antidepressants – Bupropion (dopamine‑norepinephrine), mirtazapine (sedating, appetite‑stimulating).
• Tricyclic antidepressants (TCAs) – Amitriptyline, nortriptyline – effective but higher side‑effect burden; often reserved for treatment‑resistant cases.
• Monoamine oxidase inhibitors (MAOIs) – Phenelzine, tranylcypromine – require dietary restrictions; rarely first‑line.
• Adjunctive agents – Lithium or atypical antipsychotics (e.g., aripiprazole) may augment response in treatment‑resistant depression.

Psychotherapy

• Cognitive‑behavioral therapy (CBT) – Helps identify and modify negative thought patterns; strong evidence for mild‑to‑moderate depression.
• Interpersonal therapy (IPT) – Focuses on role transitions and relationship problems.
• Behavioral activation – Encourages engagement in rewarding activities.
• Mindfulness‑based cognitive therapy (MBCT) – Reduces relapse risk.

Procedural/Neuromodulation Treatments

• Electroconvulsive therapy (ECT) – Highly effective for severe, psychotic, or treatment‑resistant depression; administered under anesthesia.
• Repetitive transcranial magnetic stimulation (rTMS) – Non‑invasive; FDA‑cleared for adults who have not responded to at least one antidepressant.
• Vagus nerve stimulation (VNS) and deep brain stimulation (DBS) – Considered only for chronic, refractory cases.

Lifestyle & Self‑Care Strategies

• Regular aerobic exercise (150 min/week) improves mood via endorphin release.
• Sleep hygiene – consistent schedule, limiting screens before bedtime.
• Balanced diet rich in omega‑3 fatty acids, folate, and vitamin D.
• Limiting alcohol and avoiding illicit substances.
• Social connection – support groups, peer counseling.

Living with Depression (major depressive disorder)

Managing depression is an ongoing process. Below are practical tips to help maintain stability and improve quality of life.

Daily Structure

• Set a realistic routine – wake, eat, work, and sleep at consistent times.
• Break tasks into small, manageable steps; use checklists or apps.

Stress Management

• Practice deep‑breathing, progressive muscle relaxation, or guided imagery for 5–10 minutes daily.
• Consider mindfulness meditation (10–15 min) to reduce rumination.

Physical Activity

• Start with short walks (10 min) and gradually increase duration and intensity.
• Combine aerobic and strength‑training exercises twice per week.

Nutrition

• Eat regular meals; include protein, whole grains, fruits, and vegetables.
• Consider a supplement of omega‑3 (e.g., 1 g EPA/DHA) after discussing with your provider.

Medication Adherence

• Take medications at the same time each day; set alarms or use a pill‑box.
• Never stop a medication abruptly without consulting your prescriber.

Social Support

• Share your experience with trusted friends or family.
• Join a depression support group (in‑person or online) for shared coping strategies.

Monitoring Symptoms

• Complete a weekly PHQ‑9 or mood diary; track worsening patterns.
• Report any increase in suicidal thoughts to a clinician immediately.

Prevention

While it may not be possible to eliminate all risk, several evidence‑based strategies can lower the likelihood of developing major depression or mitigate its severity.

• Early identification – Screen high‑risk groups (e.g., postpartum women, adolescents) using PHQ‑9 or Edinburgh Postnatal Depression Scale.
• Stress‑reduction programs – Workplace wellness initiatives, cognitive‑behavioral stress management.
• Maintain a healthy lifestyle – Regular exercise, balanced diet, adequate sleep.
• Limit substance use – Moderate alcohol intake (≤1 drink/day for women, ≤2 for men) and avoid illicit drugs.
• Foster strong social connections – Community involvement, volunteering, strong family ties.
• Treat chronic medical conditions promptly – Good glycemic control in diabetes, hypertension management.

Complications

If left untreated, major depressive disorder can lead to serious physical, emotional, and social consequences.

• Suicide – Depression is the single biggest risk factor; up to 10% of people with MDD die by suicide<sup>5</sup>.
• Chronic medical illnesses – Poor adherence to treatment regimens for diabetes, heart disease, or HIV.
• Functional impairment – Decreased work productivity, increased absenteeism, and higher unemployment rates.
• Substance use disorder – Self‑medication with alcohol or drugs.
• Social isolation – Strained relationships, divorce, or homelessness.
• Cognitive decline – Long‑standing depression is associated with an increased risk of dementia.

When to Seek Emergency Care

---

References

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM‑5). 2013.
2. World Health Organization. Depression Fact Sheet. 2022.
3. National Institute of Mental Health. Major Depression Statistics. Updated 2023.
4. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta‑analysis. Am J Psychiatry. 2000;157(10):1552‑1562.
5. Goldman-Mellor SJ, et al. Risk of suicide associated with major depressive disorder: a systematic review. J Affective Disorders. 2021;286:30‑38.
6. Mayo Clinic. Depression: Symptoms & Causes. Accessed May 2024.
7. Centers for Disease Control and Prevention. Coping with Stress. 2023.

```